Professor to cycle 60 miles to give back to the Newcastle charity supporting her research into childhood cancer
A scientist who studies a rare form of childhood cancer is joining a 60 mile cycle ride through Northumberland in support of the charity which has funded her research for more than ten years.
In her lab at The Institute of Cancer Research, London, Professor Janet Shipley carries out pioneering research into rhabdomyosarcoma – a rare cancer which particularly affects children and teenagers.
Professor Shipley’s work is generously supported by the Chris Lucas Trust, a charity set up by Lynn and Lynn Lucas in memory of their son Chris, who sadly died of the disease in 2000, aged just 18.
To give back to the charity, Professor Shipley is now preparing to take part in their flagship annual fundraising event, the Great North Bike Ride, on 25 August, ahead of the start of Childhood Cancer Awareness Month in September.
To support Professor Janet Shipley and donate to the Chris Lucas Trust to enable more pioneering work into rhabdomyosarcoma, please visit her JustGiving page.
New Clinical Trial
New trial for rhabdomyosarcoma patients
Next Event: GREAT NORTH BIKE RIDE
Sunday 29th August 2021 www.greatnorthbikeride.com
Professor Janet Shipley and her sarcoma molecular pathology team
Did you know?
Chris Lucas Trust has fundraised £2 million for childhood Rhabdomyosarcoma cancer research?
Chris Lucas Trust employs two Senior Medical Researchers for Rhabdomyosarcoma?
Hopes pinned on gene test
ICR scientists set to conquer Mount Snowdon for research into rare teenage cancer
Over £1.5 million raised
Originally from Newcastle herself, Professor Shipley will be joining around 2,000 other cyclists on a 60 mile route that runs along the stunning Northumberland coastline, finishing in Tynemouth.
Professor Shipley took part in the London to Brighton ride many years ago, and she has been occasionally cycling to and from work – which she hopes will stand her in good stead for the Great North Bike Ride.
She has already raised more than £1,000 and hopes to raise even more in aid of research into rhabdomyosarcoma – a cancer that rarely occurs in adults, but accounts for 7 per cent of all childhood cancers.
The Chris Lucas Trust has so far raised more than £1.5 million for research into rhabdomyosarcoma at The Institute of Cancer Research (ICR).
ICR thanks star fundraisers for their significant contributions to our research
founder of The Chris Lucas Trust, Lynn Lucas, were thanked at the October meeting of the ICR's Discovery Club for their phenomenal fundraising efforts to support our research.
The meeting of the Discovery Club – our special group of visionary philanthropic supporters – was held at the Royal Society of Chemistry in Piccadilly.
At the event, Head of Cancer Therapeutics Professor Raj Chopra talked about our work tackling cancers of unmet need, for which there are still few effective treatments, but with the support of donors like Tim and Lynn our researchers are making vital inroads.
Tim and Lynn's support, and those of countless others, is helping us to carry out research into these challenging diseases which would not have been possible otherwise.
Lynn Lucas, joint founder of The Chris Lucas Trust, has worked tirelessly with her husband Lynn to support our research into rhabdomyosarcoma, a rare childhood cancer which took their son Chris in 2000.
The Chris Lucas Trust has raised over £1 million for research into rhabdomyosarcoma at the ICR, and continue to fundraise through flagship events such as the Great North Bike Ride.
Their support has helped Professor Janet Shipley's lab develop a genetic test to better classify rhabdomyosarcoma patients into low and high risk groups that decide treatment intensity.
In 2017 Lynn received the NHS Hero Award for Fundraiser of the Year for her continued support for the ICR. She was also recognised by Prime Minister Theresa May when she was chosen for a Points of Light Award.
Lara Jukes, Director of Development at the ICR, said: "Tim, Lynn and their supporters are passionate and dedicated fundraisers for the ICR's cancer research, and it was an honour to celebrate their fantastic contributions to our work at our Discovery Club event.
"Finding new ways to tackle hard to treat cancers is a particular goal of ours, but it's a team effort, and without their help it would be so much harder. You are an inspiration to our researchers and through your support we will make the discoveries that defeat cancer."